REC. Rnasin rnase inhibit PCE and 2 more items

George Mason University (GMU) in Virginia awarded a contract to Promega Corporation on September 17, 2026, for the supply of molecular biology reagents and enzymes. The contract, identified as A247_PC_TXN00623937, carries a cumulative value of $1,034.00. The contract covers three distinct line items: RNAsin RNase Inhibitor (1 unit at $418.53), PCR Nucleotide Mix 10 millimolar concentration (4 units at $100.71 each), and GoScript Reverse Transcriptase (1 unit at $212.62). All items are to be delivered to GMU Purchasing.

These products represent standard molecular biology reagents used in nucleic acid research and diagnostics applications. The RNase inhibitor and reverse transcriptase enzyme are components typically utilized in RNA-based molecular techniques, while the PCR nucleotide mix serves as a reagent in polymerase chain reaction assays. The relatively modest contract value and single-delivery destination indicate this procurement supports laboratory operations at George Mason University's research or instructional facilities.